StockClub

IGC

IGCIGC Pharma, Inc.$ --
IGC Pharma, Inc.

IGC Pharma, Inc.

IGC

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q3
Revenue
0M USD
YoY +36.2%
Operating Income
-3M USD
YoY -56.6%
Net Income
-1M USD
YoY +60.3%
EPS
-0.01$
YoY +67.8%

Revenue

$869,000
FY2024 Q4$1.3M
$1.3M
Q4
FY2025 Q1$272,000
$272,000
Q1
FY2025 Q2$684,000
$684,000
Q2
FY2025 Q3$941,000
$941,000
Q3
FY2025 Q4$1.3M
$1.3M
Q4
FY2026 Q1$328,000
$328,000
Q1
FY2026 Q2$519,000
$519,000
Q2
FY2026 Q3$869,000
$869,000
Q3
Actual
$-72,000 (-7.7%)

Net Income

$-4.1M
FY2024 Q4$-13M
$-13M
Q4
FY2025 Q1$-2.4M
$-2.4M
Q1
FY2025 Q2$-4.1M
$-4.1M
Q2
FY2025 Q3$-5.9M
$-5.9M
Q3
FY2025 Q4$-7.1M
$-7.1M
Q4
FY2026 Q1$-1.6M
$-1.6M
Q1
FY2026 Q2$-3.4M
$-3.4M
Q2
FY2026 Q3$-4.1M
$-4.1M
Q3
Actual
+$1.8M (+30.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$4.1M
FY2020
$4.1M
FY2021
Actual:$898,000
FY2021
$898,000
FY2022MISS
Actual:$397,000
Est:$11.4M
FY2022MISS
$397,000
FY2023MISS
Actual:$911,000
Est:$22.2M
FY2023MISS
$911,000
FY2024BEAT
Actual:$1.3M
Est:$1.2M
FY2024BEAT
$1.3M
FY2025BEAT
Actual:$1.3M
Est:$1.2M
FY2025BEAT
$1.3M

Analyst Estimates